Enclomiphene hydrochloride

Enclomiphene hydrochloride Structure
Enclomiphene hydrochloride structure
Common Name Enclomiphene hydrochloride
CAS Number 14158-65-7 Molecular Weight 442.42100
Density N/A Boiling Point N/A
Molecular Formula C26H29Cl2NO Melting Point N/A
MSDS Chinese USA Flash Point N/A

Bone Mineral Density and Response to Treatment in Men Younger Than 50 Years with Testosterone Deficiency and Sexual Dysfunction or Infertility

J. Urol. 191(4) , 1072-6, (2014)

Purpose Testosterone deficiency is a known risk factor for osteopenia and osteoporosis in older men. Less is known about the impact of testosterone deficiency on bone mineral density in younger men.

Progesterone luteal support after ovulation induction and intrauterine insemination: a systematic review and meta-analysis

Fertil. Steril. 100(5) , 1373-80, (2013)

Objective To evaluate the effect of luteal phase P support after ovulation induction IUI.

Re: Optimization of Spermatogenesis-Regulating Hormones in Patients with Non-Obstructive Azoospermia and its Impact on Sperm Retrieval: A Multicentre Study

J. Urol. 190(6) , 2209, (2013)

Evaluation of the genotoxicity of clomiphene citrate.

Mutat. Res. Genet. Toxicol. Environ. Mutagen. 759 , 21-7, (2014)

Clomiphene citrate (CC) is a selective estrogen-receptor modulator that is primarily used to enhance follicular development in women receiving in vitro fertilization (IVF) treatment. Although some studies suggested large increases in ovarian cancer risk relat...

Infertility treatment in polycystic ovary syndrome: lifestyle interventions, medications and surgery.

Front. Horm. Res. 40 , 128-41, (2013)

Management of patients with polycystic ovary syndrome (PCOS) who wish to become pregnant should include exclusion of other diseases in the woman and additional fertility disorders in the couple. Before the initiation of any pharmacological intervention, the i...

Insulin sensitizers in polycystic ovary syndrome.

Front. Horm. Res. 40 , 83-102, (2013)

From the conceptual point of view, there are several reasons to expect that improvement of insulin sensitivity may produce several benefits in the treatment of a complex disorder like polycystic ovary syndrome (PCOS), including a decrease in insulin and andro...

Clomiphene ovulation induction and higher-order multiple pregnancy.

Aust. N. Z. J. Obstet. Gynaecol. 53(4) , 395-8, (2013)

Clomiphene citrate is a widely used treatment for ovulatory dysfunction in women seeking pregnancy. The major adverse consequence of clomiphene use is the increased risk of multiple and higher-order multiple pregnancy. Mechanisms for multiple pregnancy includ...

European survey of diagnosis and management of the polycystic ovary syndrome: results of the ESE PCOS Special Interest Group's Questionnaire.

Eur. J. Endocrinol. 171(4) , 489-98, (2014)

There is evidence for differences between endocrinologists and other specialists in their approach to diagnosis and management of the polycystic ovary syndrome (PCOS).A mailed survey consisting of a simple questionnaire aiming to understand current practice f...

Reduced lateral mobility of a fluorescent lipid analog in cell membranes of rat fibroblasts transformed by simian virus 40.

J. Clin. Endocrinol. Metab. 98(10) , 4170-5, (2013)

In order to study the difference between normal and transformed cells, lateral motion of fluorescent molecules embedded into cell membranes of rat clonal fibroblasts and its SV40-transformed derivative cells was measured by the FPR technique. The lateral diff...

Thin endometrial stripe does not affect likelihood of achieving pregnancy in clomiphene citrate/intrauterine insemination cycles.

Fertil. Steril. 100(6) , 1610-4.e1, (2013)

To determine whether there is a correlation between preovulatory endometrial stripe thickness (EST) and pregnancy rates in clomiphene citrate (CC)/IUI cycles.Retrospective cohort.Infertility clinic of an academic medical center.A total of 262 patients complet...